This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
under 5
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

Current treatment options for hemangiomas, such as propranolol, steroids and interferon, all have the potential for significantly harmful side effects. The purpose of this study is to identify potential biomarkers that can be used to design clinical trials and accelerate the delivery of new treatment alternatives to children with hemangiomas.

Provided treatments

  • Procedure: Urine collection and ultrasonography
  • Procedure: Urine collection

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01598116. The sponsor of the trial is Gayle Gordillo and it is looking for 60 volunteers for the current phase.
Official trial title:
A Prospective Longitudinal Study to Identify Biomarkers in Children With Hemangiomas.